Naas Solicitor Liam Moloney confirmed today that Medtronic had notified healthcare professionals of a Class 1 recall of the SynchromMed II Infusion system. The problem relates to the formation of a film within the pump battery which can lead to the sudden loss of therapy. It can cause therapy withdrawal symptoms.
The recall includes the SynchroMed II Implantable Infusion Pump models 8637-20 and 8637-40, distributed between May 2004 and July 8, 2011.
The drug pump is part of an infusion system designed to contain and administer prescribed drugs to a specific site. The pump delivers morphine sulphate, ziconotide and baclofen for the treatment of chronic pain, severe chronic pain and severe spasticity. It is also used in the treatment of primary or metastatic cancer.
Speaking today, Liam Moloney, healthcare Solicitor of Naas, Co, Kildare said, “Patients should carry their patient identification cards with them at all times and should contact their doctors immediately if they experience a return of symptoms or hear a device alarm. They should also report adverse events of side effects to the use of these products to the Irish Medicines Boards”.
If you have a Medtronic defibrillator and if you have suffered personal injuries as a result of the use of your device to include electric shocks you may be entitled to receive compensation. If these issues affect you please contact Liam Moloney, Solicitor, Naas, on 045 898000 or simply log onto our website www.moloneysolicitors.ie for further information concerning your rights.
